The human papillomavirus 16 E2 protein is stabilised in S phase

Article English OPEN
Johansson, Cecilia ; Graham, Sheila V. ; Dornan, Edward S. ; Morgan, Iain M. (2009)
  • Publisher: Elsevier BV
  • Journal: Virology (issn: 0042-6822, vol: 394, pp: 194-199)
  • Related identifiers: doi: 10.1016/j.virol.2009.08.046
  • Subject: Virology
    mesheuropmc: viruses

The human papillomavirus 16 E2 protein regulates transcription from, and replication of, the viral genome and is also required for segregation of the viral genome via interaction with mitotic bodies. To regulate DNA replication E2 interacts with sequences around the origin of replication and recruits the viral helicase E1 via a protein-protein interaction, which then initiates viral genome replication. The replication role of E2 must originally function in a host cell S phase. In this report, we demonstrate that E2 is stabilised in the S phase of the cell cycle and that this stabilisation is accompanied by an increase in phosphorylation of the protein. This increased phosphorylation and stability are likely required for optimum viral DNA replication and therefore identification of the enzymes involved in regulating these properties of E2 will provide targets for therapeutic intervention in the viral life cycle. Preliminary studies have identified E2 as a Cdk2 substrate demonstrating this enzyme as a candidate kinase for mediating the in vivo phosphorylation of HPV16 E2.
  • References (25)
    25 references, page 1 of 3

    Aleem, E., Berthet, C., Kaldis, P., 2004. Cdk2 as a master of S phase entry: fact or fake? Cell. Cycle 3, 35-37.

    Bellanger, S., Demeret, C., Goyat, S., Thierry, F., 2001. Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J. Virol. 75, 7244-7251.

    Benson, J.D., Howley, P.M., 1995. Amino-terminal domains of the bovine papillomavirus type 1 E1 and E2 proteins participate in complex formation. J. Virol. 69, 4364-4372.

    Boner, W., Taylor, E.R., Tsirimonaki, E., Yamane, K., Campo, M.S., Morgan, I.M., 2002. A Functional Interaction between the Human Papillomavirus 16 Transcription/ Replication Factor E2 and the DNA Damage Response Protein TopBP1. J. Biol. Chem. 277, 22297-22303.

    Bouvard, V., Storey, A., Pim, D., Banks, L., 1994. Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes. EMBO J. 13, 5451-5459.

    Donaldson, M.M., Boner, W., Morgan, I.M., 2007. TopBP1 regulates human papillomavirus type 16 E2 interaction with chromatin. J. Virol. 81, 4338-4342.

    Hanamura, A., Caceres, J.F., Mayeda, A., Franza, B.R., Krainer, A.R., 1998. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 4, 430-444.

    Hibma, M.H., Raj, K., Ely, S.J., Stanley, M., Crawford, L., 1995. The interaction between human papillomavirus type 16 E1 and E2 proteins is blocked by an antibody to the N-terminal region of E2. Eur. J. Biochem. 229, 517-525.

    Hu, Y., Clower, R.V., Melendy, T., 2006. Cellular topoisomerase I modulates origin binding by bovine papillomavirus type 1 E1. J. Virol. 80, 4363-4371.

    Loo, Y.M., Melendy, T., 2004. Recruitment of replication protein A by the papillomavirus E1 protein and modulation by single-stranded DNA. J. Virol. 78, 1605-1615.

  • Metrics
    No metrics available
Share - Bookmark